Pyrrolidine modulators of ccr5 chemokine receptor activity
CA 2425288 A1 · Owner: Gentry, Amy · Inventors: Chapman, Kevin T.; Chen, Liya; Kim, Dooseop
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Pyrrolidine compounds of Formula (I), (wherein R1 R2, R3, R4, R5, R6a, R6b, R7 and R8 are defined herein) are described. The compounds are modulators of CCR5 chemokine receptor activity. The compounds are useful for example, in , the prevention or treatment of infection by HIV and the treatment of AIDS as , compounds or pharmaceutically acceptable salts or as ingredients in , pharmaceutical compositions optionally in combination with other antivirals immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 9, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 9, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 9, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.